4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0001127602-16-065405
EVP, Chief Financial Officer acquired 10,413 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Burke Willaim P EVP, Chief Financial Officer | 2016-10-25 | Grant or award | +10,413 | $34.21 | $356,229 | 10,413 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Burke Willaim P EVP, Chief Financial Officer | 2016-10-25 | Grant or award · Non-qualified Stock Option (Right to Buy) | +44,926 | $34.21 | $1,536,918 | 44,926 | D: show line 2 in the form | |||
| Burke Willaim P EVP, Chief Financial Officer | 2016-10-25 | Grant or award · Performance Shares | +20,827 | 20,827 | D: show line 3 in the form |
Loading xslF345X03/form4.xml…